Creo Medical Group plc (CREO.L)
Creo Medical Group plc, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for flexible endoscopy; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device designed for soft tissue ablation; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highly perfused tissues. In addition, it provides endotherapy accessories comprising ScopeSnare, an energy-based polypectomy snares; ScopeSnare Cold, a cutting wire for use in endoscopically in the removal of diminutive, sessile and pedunculated polyps, and tissue from within the GI tract; ScopeClip, a single-use rotational and repositionable hemoclips; ScopeBite, a portfolio of biopsy forceps; ScopeGrasp, a portfolio of grasping forceps; and ScopeInject, an injection needle. Creo Medical Group plc was founded in 2003 and is based in Chepstow, the United Kingdom.
Company Info
ISIN | GB00BZ1BLL44 |
---|---|
Sector | Healthcare |
Industry | Medical Devices |
Highlights
Market Cap | £127.60M |
---|---|
EPS | -£0.07 |
PE Ratio | 4.53 |
Revenue (TTM) | £30.80M |
Gross Profit (TTM) | £11.59M |
EBITDA (TTM) | -£21.40M |
Year Range | £22.72 - £50.00 |
Target Price | £89.50 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: CREO.L vs. SPYV, CREO.L vs. QQQ, CREO.L vs. BRK-B
Performance
Performance Chart
The chart shows the growth of an initial investment of £10,000 in Creo Medical Group plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Creo Medical Group plc had a return of -23.26% year-to-date (YTD) and 44.08% in the last 12 months.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | -23.26% | 11.18% |
1 month | 2.32% | 5.60% |
6 months | 7.79% | 17.48% |
1 year | 44.08% | 26.33% |
5 years (annualized) | -30.08% | 13.16% |
10 years (annualized) | N/A | 10.99% |
Monthly Returns
The table below presents the monthly returns of CREO.L, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | -8.70% | -29.17% | 15.13% | 5.11% | -23.26% | ||||||||
2023 | -22.28% | 43.95% | -6.19% | -7.55% | 0.41% | 42.28% | -7.14% | 2.31% | -5.26% | 3.17% | -0.00% | 41.54% | 82.18% |
2022 | -18.46% | 7.41% | -14.56% | -4.93% | -5.66% | -8.00% | -19.02% | -8.05% | -21.17% | -16.20% | -15.47% | -33.99% | -83.05% |
2021 | 6.19% | 7.28% | -2.26% | -4.63% | 2.91% | -6.13% | 3.02% | -12.68% | -3.35% | -10.12% | -11.58% | 8.36% | -23.20% |
2020 | -4.14% | -4.61% | -29.61% | 12.45% | 16.79% | 38.56% | -8.49% | -6.96% | -6.93% | -11.90% | 13.51% | 15.48% | 7.18% |
2019 | 15.08% | -10.04% | -6.55% | -0.26% | 3.39% | -8.31% | -17.03% | -12.91% | 11.03% | 27.40% | 6.18% | -8.35% | -9.05% |
2018 | 5.04% | 13.70% | 36.75% | 17.62% | -1.50% | -5.70% | 20.16% | 11.74% | 35.14% | -15.11% | -6.81% | 11.80% | 186.33% |
2017 | 15.95% | -3.17% | -9.84% | 11.52% | -7.61% | 1.18% | -1.16% | -6.47% | 3.77% | -3.64% | -12.58% | -0.00% | -14.72% |
2016 | 1.88% | 1.88% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of CREO.L is 71, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
CREO.L (Creo Medical Group plc)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Creo Medical Group plc (CREO.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Creo Medical Group plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Creo Medical Group plc was 92.35%, occurring on Feb 13, 2023. The portfolio has not yet recovered.
The current Creo Medical Group plc drawdown is 85.47%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-92.35% | Oct 2, 2018 | 1102 | Feb 13, 2023 | — | — | — |
-39.29% | Jan 5, 2017 | 252 | Jan 4, 2018 | 45 | Mar 8, 2018 | 297 |
-15.65% | May 8, 2018 | 36 | Jun 27, 2018 | 13 | Jul 16, 2018 | 49 |
-13.32% | Sep 18, 2018 | 2 | Sep 19, 2018 | 5 | Sep 26, 2018 | 7 |
-11.81% | Mar 9, 2018 | 8 | Mar 20, 2018 | 10 | Apr 5, 2018 | 18 |
Volatility
Volatility Chart
The current Creo Medical Group plc volatility is 11.13%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |